Evidence map›Paper›PMID 29748422›Full record

SynthesisStroke2018

Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review.

Kui Kai Lau, Caroline E Lovelock, Linxin Li, Michela Simoni, Sergei Gutnikov, Wilhelm Küker, Henry Ka Fung Mak, Peter M Rothwell

3 registry-linked trialsOpen access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Stroke, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04504864 phase4unknown statusnot on this mapstarted 2020, after this paper: background citation

Low-dose Aspirin Therapy in Patients With Non-Cardioembolic Ischemic Stroke and Microbleeds

TypeinterventionalSponsorXijing HospitalRan2020 to 2022Enrolled400ConditionsIschemic StrokeArmslow-dose aspirin, conventional-does aspirin
NCT05032053 recruitingnot on this mapstarted 2022, after this paper: background citation

Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

Typeobservational_patient_registrySponsorXijing HospitalRan2022 to 2027Enrolled3,000ConditionsIschemic StrokeArmsAntithrombotic drugs
NCT05690997 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Effect of Intensive Blood Pressure Control on Cerebral Blood Flow and Cognition in Ischaemic Stroke Patients With Severe Cerebral Small Vessel Disease

TypeinterventionalSponsorThe University of Hong KongRan2023 to 2025Enrolled104ConditionsSmall Vessel Cerebrovascular Disease, StrokeArmsIntensive treatment, Standard treatment
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kui Kai LauFrom the Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom (K.K.L., C.E.L., L.L., M.S., S.G., W.K., P.M.R.).
Caroline E LovelockFrom the Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom (K.K.L., C.E.L., L.L., M.S., S.G., W.K., P.M.R.).
Linxin LiFrom the Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom (K.K.L., C.E.L., L.L., M.S., S.G., W.K., P.M.R.).
Michela SimoniFrom the Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom (K.K.L., C.E.L., L.L., M.S., S.G., W.K., P.M.R.).
Sergei GutnikovFrom the Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom (K.K.L., C.E.L., L.L., M.S., S.G., W.K., P.M.R.).
Wilhelm KükerFrom the Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom (K.K.L., C.E.L., L.L., M.S., S.G., W.K., P.M.R.).
Henry Ka Fung MakDepartment of Diagnostic Radiology (H.K.F.M.), Li Ka Shing Faculty of Medicine, University of Hong Kong.
Peter M RothwellFrom the Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom (K.K.L., C.E.L., L.L., M.S., S.G., W.K., P.M.R.) peter.rothwell@ndcn.ox.ac.uk.
University of Oxford · GB

Funding

British Heart FoundationWellcome Trust
6 · The paper itself

Abstract

background and purposeIn patients with transient ischemic attack/ischemic stroke, microbleed burden predicts intracerebral hemorrhage (ICH), and ischemic stroke, but implications for antiplatelet treatment are uncertain. Previous cohort studies have had insufficient follow-up to assess the time course of risks, have not stratified risks by antithrombotic use, and have not reported extracranial bleeds or functional outcome of ICH versus ischemic stroke.

methodsIn 2 independent prospective cohorts with transient ischemic attack/ischemic stroke (Oxford Vascular Study/mainly white; University of Hong Kong/mainly Chinese), antiplatelet treatment was started routinely irrespective of microbleed burden. Risks, time course and outcome of ICH, extracranial bleeds, and recurrent ischemic events were determined and stratified by microbleed burden (0 versus 1, 2-4, and ≥5), adjusting for age, sex, and vascular risk factors.

resultsMicrobleeds were more frequent in the Chinese cohort (450 of 1003 versus 165 of 1080;

conclusionsIn white and Chinese patients with ≥5 microbleeds, withholding antiplatelet drugs during the first year after transient ischemic attack/ischemic stroke may be inappropriate. However, the risk of ICH may outweigh any benefit thereafter.

Indexed as

AdultAgedAged, 80 and overBrain IschemiaCerebral HemorrhageCohort StudiesFemaleHumansIschemic Attack, TransientMaleMiddle AgedPlatelet Aggregation InhibitorsRisk FactorsStrokeTreatment OutcomePlatelet Aggregation Inhibitorscerebral small vessel diseasemagnetic resonance imagingstroketransient ischemic attack

Identifiers

PMID29748422
PMCPMC5976229
OpenAlexW2799410309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.